For people with T2D, a phase 2 trial showed that 12 weeks of efinopegdutide achieve up to 7.9% WL (compared to 0.7% WL with placebo) without actual improvement in HbA1c [78]
Consumer product group (CPG) manufacturers are taking note and responding to those facing the more common side-effects, launching new products to support muscle gain that are high in protein and nutrient dense
Available batch-specific analytical documentation is published on the corresponding 10mg, 20mg, or 30mg product page
doi: 10.1016/j.therap.2020.02.024
If youre microdosing, using FDA-approved brand-name medications with your doctors guidance is significantly safer than compounded alternatives
Kind Patches contain some ingredients with modest research behind them, but the product makes scientifically implausible claims about transdermal delivery and GLP-1 effects